New Jersey Federal Judge Must Revisit Schizophrenia Drug Patent Dispute
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on April 1 remanded a dispute over the validity of a patent directed to an injectable treatment for adult schizophrenia, with...To view the full article, register now.
Already a subscriber? Click here to view full article